METASTATIC UROTHELIAL CARCINOMA
Clinical trials for METASTATIC UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of cancer drugs tested in desperate cases
Disease control TerminatedThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy for tough bladder cancer cases shows early promise
Disease control TerminatedThis study tested a combination of two drugs, selinexor and pembrolizumab, in people with advanced bladder cancer who either couldn't take the standard chemo drug cisplatin or whose cancer got worse after cisplatin. The goal was to find the best dose and see if the combo could sh…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mamta Parikh • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Bladder cancer drug combo study halted early
Disease control TerminatedThis study looked at whether adding an immunotherapy drug (pembrolizumab) to a targeted therapy (pemigatinib) works better than the targeted therapy alone or standard care for people with advanced bladder cancer that has a specific gene change (FGFR3). The study was stopped early…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC